iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 84.06
+3.86 (4.81%)
Jul 31, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 26.33 billion as of July 31, 2026. Its market cap has increased by 54.45% in one year.
Market Cap
26.33B
Enterprise Value
27.75B
Revenue
2.46B
Ranking
n/a
PE Ratio
36.80
Stock Price
84.06
ChartMarket Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 26.33B, an increase of 126.73%. That is a compound annual growth rate of 14.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 26.33B | 23.32% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 40.91B |
| Imeik Technology Development | 32.86B |
| Intco Medical Technology | 32.68B |
| Andon Health | 28.71B |
| Zhende Medical | 24.00B |
| Winner Medical | 17.86B |
| Shenyang Xingqi Pharmaceutical | 15.18B |
| Micro-Tech (Nanjing) Co.,Ltd | 13.60B |